CARCINOGENICITY STUDY OF FECAPENTAENE-12 DIACETATE ON SKIN PAINTING IN SENCAR MICE

被引:4
作者
DEVOR, DE
HENNEMAN, JR
KEEFER, LK
LOGSDON, DL
RICE, JM
STREETER, AJ
WARD, JM
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,COMPARAT CARCINOGENESIS LAB,FREDERICK,MD 21702
[2] NCI,FREDERICK CANC RES & DEV CTR,PRI DYNCORP,ANIM SCI PROGRAM,FREDERICK,MD 21702
[3] NCI,FREDERICK CANC RES & DEV CTR,PRI DYNCORP,BIOL CARCINOGENESIS LAB,FREDERICK,MD 21702
关键词
FECAPENTAENE-12; DIACETATE; TUMOR INITIATION STUDY; ALPHA-TOCOPHEROL;
D O I
10.1016/0304-3835(91)90187-M
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the effects of both diol esterification and coadministration with antioxidant on the tumorigenicity of fecapentaene-12 (FP-12) preparations, diacetylfecapentaene-12 (DAFP-12) in dimethylsulfoxide (DMSO) was applied to SENCAR mouse skin with or without the stabilizer, vitamin E, twice/week for 5 weeks, following which all animals were promoted for up to 25 weeks by weekly applications of 12-O-tetradecanoylphorbol-13-acetate (TPA). While positive controls receiving 7,12-dimethylbenz-[a]anthracene (DMBA) instead of DAFP-12 in a similar protocol all developed papillomas (average of 23/animal), papilloma incidence in mice given DAFP-12 did not differ significantly from that of the vehicle control. We conclude that DAFP-12 shows little or no tumor initiating activity for mouse skin even when coadministered with vitamin E.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 19 条
[11]  
SCHIFFMAN MH, 1989, CANCER RES, V49, P1322
[12]  
SHAMSUDDIN A M, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P87
[13]   DECOMPOSITION AND QUALITY-CONTROL CONSIDERATIONS IN BIOLOGICAL WORK WITH FECAPENTAENE PREPARATIONS [J].
STREETER, AJ ;
DONOVAN, PJ ;
ANJO, T ;
OHANNESIAN, L ;
SHEFFELS, PR ;
WU, PR ;
KEEFER, LK ;
ANDREWS, AW ;
BRADFORD, WW ;
REIST, EJ ;
RICE, JM .
CHEMICAL RESEARCH IN TOXICOLOGY, 1989, 2 (03) :162-168
[14]   THE PRECURSORS OF FECAPENTAENES - PURIFICATION AND PROPERTIES OF A NOVEL PLASMALOGEN [J].
VANTASSELL, RL ;
PICCARIELLO, T ;
KINGSTON, DGI ;
WILKINS, TD .
LIPIDS, 1989, 24 (05) :454-459
[15]   THE BACTERIAL MUTAGENICITY OF SYNTHETIC ALL-TRANS FECAPENTAENE-12 CHANGES WHEN ASSAYED UNDER ANAEROBIC CONDITIONS [J].
VENITT, S ;
BOSWORTH, D .
MUTAGENESIS, 1988, 3 (02) :169-173
[16]   STRUCTURE, CHEMICAL-REACTIVITY, AND INVITRO MUTAGENIC ACTIVITY IN A SERIES OF FECAPENTAENE ANALOGS [J].
VOOGD, CE ;
VERTEGAAL, LBJ ;
VANDERSTEEG, M ;
VANDERGEN, A ;
MOHN, GR .
MUTATION RESEARCH, 1990, 243 (03) :195-199
[17]   DIFFERENTIAL CARCINOGENIC EFFECTS OF INTRAPERITONEAL INITIATION WITH 7,12-DIMETHYLBENZ(A)ANTHRACENE OR URETHANE AND TOPICAL PROMOTION WITH 12-O-TETRADECANOYLPHORBOL-13-ACETATE IN SKIN AND INTERNAL TISSUES OF FEMALE SENCAR AND BALB/C MICE [J].
WARD, JM ;
REHM, S ;
DEVOR, D ;
HENNINGS, H ;
WENK, ML .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1986, 68 :61-68
[18]   INACTIVITY OF FECAPENTAENE-12 AS A RODENT CARCINOGEN OR TUMOR INITIATOR [J].
WARD, JM ;
ANJO, T ;
OHANNESIAN, L ;
KEEFER, LK ;
DEVOR, DE ;
DONOVAN, PJ ;
SMITH, GT ;
HENNEMAN, JR ;
STREETER, AJ ;
KONISHI, N ;
REHM, S ;
REIST, EJ ;
BRADFORD, WW ;
RICE, JM .
CANCER LETTERS, 1988, 42 (1-2) :49-59
[19]   CARCINOGENICITY TESTS OF FECAPENTAENE-12 IN MICE AND RATS [J].
WEISBURGER, JH ;
JONES, RC ;
WANG, CX ;
BACKLUND, JYC ;
WILLIAMS, GM ;
KINGSTON, DGI ;
VANTASSELL, RL ;
KEYES, RF ;
WILKINS, TD ;
DEWIT, PP ;
VANDERSTEEG, M ;
VANDERGEN, A .
CANCER LETTERS, 1990, 49 (02) :89-98